Capricor Therapeutics, Inc.
CAPR · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 6, 2026 | — | 2.08M | — | -0.58 | — |
| 2026 Q1 | May 12, 2026 | — | 40.00M | -0.59 | -0.55 | -3.78% |
| 2025 Q4 | March 12, 2026 | — | 525.00K | -0.62 | -0.51 | -8.74% |
| 2025 Q3 | November 10, 2025 | — | 600.00K | -0.54 | -0.54 | +11.51% |
| 2025 Q2 | August 11, 2025 | — | 480.00K | -0.57 | -0.48 | -6.27% |
| 2025 Q1 | May 13, 2025 | — | 3.16M | -0.53 | -0.33 | +5.07% |
| 2024 Q4 | March 19, 2025 | 11.13M | 5.50M | -0.16 | -0.31 | +17.51% |
| 2024 Q3 | November 13, 2024 | 2.26M | 9.87M | -0.38 | -0.34 | +9.34% |
| 2024 Q2 | August 7, 2024 | 3.97M | 3.58M | -0.35 | -0.32 | +8.99% |
| 2024 Q1 | May 13, 2024 | 4.91M | 9.70M | -0.31 | -0.11 | -4.41% |
| 2023 Q4 | February 29, 2024 | 12.09M | 10.60M | -0.02 | -0.23 | +8.69% |
| 2023 Q3 | November 14, 2023 | 6.19M | 10.90M | -0.25 | -0.27 | +6.64% |
| 2023 Q2 | August 7, 2023 | 3.92M | 1.50M | -0.29 | -0.34 | +21.66% |
| 2023 Q1 | May 11, 2023 | 2.99M | 500.00K | -0.31 | -0.32 | -1.95% |
| 2022 Q4 | March 15, 2023 | 959.90K | 10.00K | -0.31 | -0.33 | +1.90% |
| 2022 Q3 | November 10, 2022 | 1.59M | 420.00K | -0.26 | -0.28 | -7.14% |